Details for 2010819438

Up to date per 04.04.2026

Actions

Title / Product Name

Kombination enthaltend den MEK inhibitor N-{3-[3-Cyclopropyl-5-(2-fluor-4-iod- phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamid und den Akt inhibitor N-{(1S)-2-Amino-1-[(3-fluorphenyl)methyl]ethyl}-5-chlor-4-(4-chlor-1- methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamid

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2010819438

EP Publication Number

2480085

E-Number

695176

Language

PCT Number

US10049952

Publication Date

01.08.2012 A

12.11.2014 B1

Registration Date

12.11.2014

AT Publication Date

15.11.2014

Application Date

23.09.2010

Registration Number

Priorities

23.09.2009

245027 P

IPC

A01N 43/54 20060101AFI20130221BHEP

Maximum Duration of Protection

23.09.2030

Owner

GlaxoSmithKline LLCCorporation Service Company 2711 Centreville Road Suite 400 Wilmington, Delaware 19808US

Representative

No representatives present

Inventor

DUMBLE, Melissa20 Kingsbridge Road Piscataway NJ 08854US

GILMER, TonaFive Moore Drive Research Triangle Park NC 27709US

KUMAR, Rakesh1250 South Collegeville Road Collegeville PA 19426US

LEBOWITZ, Peter, F.1250 South Collegeville Road Collegeville PA 19426US

MORRIS, Shannon, RenaeFive Moore Drive Research Triangle Park NC 27709US

LAQUERRE, Sylvie709 Swedeland Road King Of Prussia PA 19406US